- Clinical Areas /
- Rare Diseases
Rare Diseases
Langerhans Cell Histiocytosis: Pathological Cell Accumulation
This excerpt from a Mechanism of Action (MOA) animation highlights a core feature of Langerhans Cell Histiocytosis (LCH)—the abnormal accumulation and clumping of cells within various tissues. The disease begins with a dysregulation in cell behavior, leading to an overgrowth of cells that start to cluster in areas like the skin, bones, and lungs. [1,2]
These cells—visualized here as generic, round forms—begin to accumulate and form dense masses, disrupting the normal function of affected tissues. This sequence illustrates the progressive nature of LCH, where seemingly isolated cellular changes escalate into significant tissue involvement and clinical symptoms, shedding light on the early cellular processes behind this rare disease. [3,4]
References:
-
Allen, C. E., & Geller, M. A. (2013). Langerhans cell histiocytosis: Current concepts and evolving paradigms. Hematology/Oncology Clinics of North America, 27(3), 387–413.
-
Grois, N., et al. (2011). Long-term outcomes of Langerhans cell histiocytosis: A retrospective analysis of 207 patients. Journal of Clinical Oncology, 29(9), 1111-1118.
-
Weitzman, S. (2016). Langerhans cell histiocytosis: A review of the disease and its treatment. Blood, 128(4), 394-402.
-
Arceci, R. J., & Shulman, S. T. (2007). Histiocytosis syndromes of childhood. Hematology/Oncology Clinics of North America, 21(3), 659–681.
Rare Diseases Medical Animation FAQs
How can animation help explain a rare disease?
Rare diseases can be challenging to communicate because even experienced audiences may have limited familiarity with the underlying biology. Animation can establish the healthy tissue context, introduce the relevant cell type, and show the pathological process in a direct, memorable way.
Why is “cell accumulation” hard to picture without animation?
The phrase “pathological cell accumulation” can sound abstract. A visual sequence can show where the cells are located, how their presence alters the tissue environment, and why that change is clinically meaningful within the disease narrative.
How can rare-disease animation support different audiences?
The same core scientific story can support education, internal alignment, advocacy, or investor communication when adapted appropriately. For a rare disease, a clear visual explanation can be particularly valuable in establishing shared understanding among audiences with different levels of prior knowledge.
Next Steps
If you are interested in speaking to a medical animation expert, please get in touch.
Get in touch